NOP58 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.6286971771251E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.0636999947522E-08 |
Normal-vs-Stage2 |
5.773300E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.023000E-04 |
Stage1-vs-Stage2 |
7.161600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.931020E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.959420E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.18458584555492E-12 |
Normal-vs-AfricanAmerican |
1.897760E-01 |
Normal-vs-Asian |
4.327900E-02 |
Caucasian-vs-AfricanAmerican |
4.011000E-01 |
Caucasian-vs-Asian |
9.106400E-01 |
AfricanAmerican-vs-Asian |
4.562000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.98909999582497E-08 |
Normal-vs-Female |
4.85619999768261E-08 |
Male-vs-Female |
6.323800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.11289999999931E-05 |
Normal-vs-Extreme_Weight |
3.11500000005349E-06 |
Normal-vs-Obese |
6.37969999999211E-05 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.654400E-01 |
Normal_Weight-vs-Obese |
5.602000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.018600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.263500E-02 |
Normal-vs-Age(41-60Yrs) |
9.00859999930503E-08 |
Normal-vs-Age(61-80Yrs) |
3.47740000128383E-08 |
Normal-vs-Age(81-100Yrs) |
3.820800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.401800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.160000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.517200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.719200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.452800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.684000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.532800E-01 |
Normal-vs-Grade 3 |
5.463800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.638800E-01 |
Grade 2-vs-Grade 4 |
9.532800E-01 |
Grade 3-vs-Grade 4 |
5.463800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.73300287850975E-11 |
Normal-vs-N1 |
5.022200E-03 |
N0-vs-N1 |
5.682100E-02 |
|
|